Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC Guidance on the Use of Influenza Antiviral Agents and Rapid Influenza Diagnostic Tests During the 2010-2011 Influenza Season

Health Alert Network logo.

This is an official

CDC HAN INFOService

Distributed via the CDC Health Alert Network
Friday, January 14, 2011, 16:11 EDT (4:11 PM EDT)
CDCHAN-00318-2011-01-14-UPD-N

Summary

As influenza activity increases in the United States, clinicians are urged to consult CDC guidance on the use of influenza antiviral agents and rapid influenza diagnostic tests this season. Updated recommendations on the use of antiviral medications will be published in an upcoming Morbidity and Mortality Weekly Report (MMWR), but an interim version of the recommendations is currently available on CDC's website at http://www.cdc.gov/flu/professionals/antivirals/index.htm. The updated guidance for health care professionals on the use of rapid influenza diagnostic tests is available at http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm. For the most recent summary of influenza activity in the United States, consult the CDC influenza surveillance report FluView at http://www.cdc.gov/flu/weekly/fluactivitysurv.htm.

Recommendations

Antiviral Agents Guidance:

The recommendations on the use of influenza antiviral agents contain information on treatment and chemoprophylaxis of influenza virus infection, and also provide a summary of the effectiveness and safety of antiviral medications. Highlights include recommendations for the following:

  • early empiric antiviral treatment of suspected or confirmed influenza among people with severe, complicated, or progressive illness or those hospitalized for influenza;
  • early empiric antiviral treatment of suspected or confirmed influenza among people at higher risk for influenza complications;
  • use of either oseltamivir or zanamivir for influenza A and B treatment or chemoprophylaxis, and recommendations not to use rimantadine or amantadine as influenza antiviral medications due to high levels of resistance to these medications among circulating influenza A viruses;
  • use of antiviral medications among children younger than 1 year of age;
  • use of local data on influenza virus circulation and influenza testing of respiratory specimens from patients with suspected influenza, when available, to help inform clinicians about influenza circulation; and
  • consideration of antiviral treatment for any previously healthy, non high-risk symptomatic outpatient with confirmed or suspected influenza, based upon clinical judgment, if treatment can be initiated within 48 hours of illness onset.

Antiviral Agents Guidance:

The recommendations on the use of influenza antiviral agents contain information on treatment and chemoprophylaxis of influenza virus infection, and also provide a summary of the effectiveness and safety of antiviral medications. Highlights include recommendations for the following:

  • use of rapid influenza diagnostic tests when a positive result will change the clinical management of patients or change outbreak control strategies in a population, especially if the setting includes hospitalized patients or persons at high risk for influenza-associated complications;
  • avoiding the use of negative rapid test results to guide decisions regarding treating patients with influenza antiviral medications due to the suboptimal sensitivity of rapid tests;
  • evaluation of rapid diagnostic test results in the context of other available clinical and epidemiological information; and
  • consideration of further influenza laboratory testing in the following circumstances:
    • when a patient tests negative by rapid test during periods of high influenza activity;
    • when a patients tests positive by rapid test during periods of low influenza activity; or
    • when a patient has had recent close exposure to pigs, poultry, or other animals and novel influenza A virus infection is possible.

For More Information

For Information on Use of Influenza Antiviral Agents During the 2010-2011 Influenza Season go to: http://www.cdc.gov/flu/professionals/antivirals/index.htm

For Information on Use of Rapid Influenza Diagnostic Tests for the 2010-2011 Influenza Season go to: http://www.cdc.gov/flu/professionals/diagnosis/

For other inquiries, please visit http://www.cdc.gov/flu or call CDC's toll-free information line, 800-CDC-INFO (800-232-4636)

The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national and international organizations.

Department of Health and Human Services

HAN Message Types

  • Health Alert: Conveys the highest level of importance; warrants immediate action or attention. Example: HAN00001
  • Health Advisory: Provides important information for a specific incident or situation; may not require immediate action. Example: HAN00346
  • Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action. Example: HAN00342
  • Info Service: Provides general information that is not necessarily considered to be of an emergent nature. Example: HAN00345

###
This message was distributed to state and local health officers, state and local epidemiologists, state and local laboratory directors, public information officers, HAN coordinators, and clinician organizations.
###

Ready: Prepare. Plan. Stay Informed.Social Media at CDC Emergency

TOP